Mostafa Bahremand

Mostafa Bahremand

Auto-generated profile, based on publicly available information

Mostafa Bahremand

Clinical Research Development Center, Imam Ali and Taleghani Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2015 in Nephro-Urology Monthly
Verified
Journal Article
Open access
PDF file
ZSZahra Saadat
Zahra Saadat
FNFarahnaz Nikdoust
Farahnaz Nikdoust
HAHossein Aerab-Sheibani
Hossein Aerab-Sheibani
MBMostafa Bahremand
Mostafa Bahremand
ESElham Shobeiri
Elham Shobeiri
DMDonald E. Morisky
Donald E. Morisky
Background: Comorbidity has been noted as a potential barrier to proper adherence to antihypertensive medications. Objectives: We decided to investigate whether comorbidity could significantly affect adherence of Iranian patients with hypertension to their medication regimen. Patients and Methods: Two hundred and eighty consecutive hypertensive patients were interviewed in 4 cities of Iran. The 8-item Morisky medication adherence scale (MMAS-8) (validated in Persian) was used to assess medication adherence. This scale determines adherence by scores as lower than 6 (low adherence), 6 or 7 (moderate adherence), and 8 (high adherence). Comorbidity was considered as any concomitant medical condition, which necessitates the patient to take medicine for a minimum of 6 months prior to the interviews. Results: The most common comorbid conditions were ischemic heart disease (65 patients, 23.2%), diabetes mellitus (55 patients, 19.6%), and dyslipidemia (51 patients, 18.2%). Mean (± SD) MMAS-8 score in comorbid group was 5.68 (± 1.85) and in non-comorbid hypertensive patients, it was 5.83 (± 1.91) (P = 0.631). Mean (± SD) number of comorbidities was 1.53 (± 0.75) in low adherence group compared to 1.54 (± 0.77) in moderate/high adherers (P = 0.98). With increasing the number of comorbid diseases, the proportion of patients with high adherence decreased successively from 20% in those with no comorbid disease to 14.1% in those with one or two comorbid conditions, and finally 11.1% in those with 3 to 5 comorbid conditions. Conclusions: With increasing the number of comorbid conditions, the proportion of patients with high adherence decreases. In our opinion, this finding is a useful clinical note for healthcare providers when managing patients with hypertension who have other medical problems at the same time. Keywords: Hypertension; Comorbidity; Iran; Medication adherence; Antihypertensive agents

17 May 2015 in Global Journal of Health Science
Verified
Journal Article
Open access
MBMostafa Bahremand
Mostafa Bahremand
MAMostafa Alikhani
Mostafa Alikhani
AZAli Zakiei
Ali Zakiei
PJParisa Janjani
Parisa Janjani
AAAbbas Aghei
Abbas Aghei
Application of psychological interventions is essential in classic treatments for patient with cardiac diseases. The present study compared cognitive emotion regulation strategies, positive affect, and negative affect for cardiac patients with healthy subjects. This study was a case-control study. Fifty subjects were selected using convenient sampling method from cardiac (coronary artery disease) patients presenting in Imam Ali medical center of Kermanshah, Iran in the spring 2013. Fifty subjects accompanied the patients to the medical center, selected as control group, did not have any history of cardiac diseases. For collecting data, the cognitive emotion regulation questionnaire and positive and negative affect scales were used. For data analysis, multivariate analysis of variance (MANOVA) Was applied using the SPSS statistical software (ver. 19.0). In all cognitive emotion regulation strategies, there was a significant difference between the two groups. A significant difference was also detected regarding positive affect between the two groups, but no significant difference was found regarding negative affect. We found as a result that, Having poor emotion regulation strategies is a risk factor for developing heart diseases.Keywords: cognitive emotion regulation, positive affect, negative affect, cardiac disease

29 October 2014 in Global Journal of Health Science
Verified
Journal Article
Open access
PDF file
MBMostafa Bahremand
Mostafa Bahremand
ARAlireza Rai
Alireza Rai
MAMostafa Alikhani
Mostafa Alikhani
SMSamira Mohammadi
Samira Mohammadi
KSKaroon Shahebrahimi
Karoon Shahebrahimi
PJParisa Janjani
Parisa Janjani
This study was aimed at describing the mediating role of resiliency in the relationship between family functioning and mental health in patients with type 2 diabetes mellitus. This descriptive research was a correlational study. A total of 225 individuals were chosen by simple random sampling technique from type 2 diabetic patients presented to diabetes care centers in Kermanshah in 2014 in Iran. The 12-item General Health Questionnaire (GHQ-12), the Family Assessment Device (FAD) and the Resilience Scale (CD-RISC) were used to collect the required data. The collected data were analyzed using the Pearson's correlation test and To study the mediating role of resiliency in family functioning and mental health interaction, the path analysis method was applied. The results showed that there is a relationship between family functioning, resilience and mental health. Resilience plays a mediating role between family functioning and mental health. Therefore, paying attention to resilience in patients may lead to improving mental health in diabetic patients.

1 January 2015 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
MBMostafa Bahremand
Mostafa Bahremand
MSMozhgan Saeidi
Mozhgan Saeidi
SKSaeid Komasi
Saeid Komasi
Bahremand M, et al. Korean J Fam Med. 2015 Jul;36(4):180-185. http://dx.doi.org/10.4082/kjfm.2015.36.4.180

1 January 2016 in American Journal of Therapeutics
Verified
Journal Article
Closed access
AEAzadeh Eshraghi
Azadeh Eshraghi
ATAzita Hajhossein Talasaz
Azita Hajhossein Talasaz
JSJamshid Salamzadeh
Jamshid Salamzadeh
MSMojtaba Salarifar
Mojtaba Salarifar
HPHamidreza Pourhosseini
Hamidreza Pourhosseini
MBMohammad Ali Boroumand
Mohammad Ali Boroumand
During percutaneous coronary intervention (PCI), trauma occurs in the arterial endothelium, resulting in platelet activation and aggregation. As platelet aggregation may lead to coronary thrombosis, antiplatelet agents are essential adjunctive therapies in patients undergoing PCI. The aim of this study was to determine the effect of the intracoronary administration of high-dose N-acetylcysteine (NAC) for the evaluation of its antiplatelet effects in human subjects. In this triple-blind trial, 147 patients undergoing primary PCI were enrolled. Finally, 100 patients were randomized to receive high-dose intracoronary NAC (100 mg/kg bolus, followed by 10 mg·kg⁻¹·h⁻¹ intracoronary continued intravenously for 12 hours) (n = 50) or dextrose solution (n = 50). Platelet activation biomarkers were measured before and 24 hours after the procedure. Secondary end points, comprising all-cause death, reinfarction, and target-vessel revascularization, were assessed at 30 days and 2 years. In comparison with the placebo, NAC could not reduce the level of platelet activation biomarkers within a 24-hour period after its prescription. Major adverse clinical events at 30 days and 2 years were infrequent and not statistically different between the 2 groups. Our results revealed that NAC, compared with the placebo, did not provide an additional clinical benefit as an effective antiplatelet agent after PCI.

30 April 2015 in The Korean Journal of Pain
Verified
Journal Article
Open access
PDF file
MBMostafa Bahremand
Mostafa Bahremand
GMGholamreza Moradi
Gholamreza Moradi
MSMozhgan Saeidi
Mozhgan Saeidi
SMSamira Mohammadi
Samira Mohammadi
SKSaeid Komasi
Saeid Komasi
Patients suffering from non-cardiac chest pain (NCCP) can interpret their chest pain wrongly despite having received a correct diagnosis. The objective of this study was to compare the efficacy of the relaxation method with metaphor therapy for reducing irrational beliefs and pain severity in patients with NCCP.Using a randomized controlled trial, 33 participants were randomly divided into a relaxation training group (n= 13), a metaphor therapy group (n = 10), and a control group (n = 10), and were studied for 4 weeks. The two tools used in this research were the Brief Pain Inventory (BPI) index for determining the degree of pain and the short version of the Jones Irrational Belief Test. Metaphor therapy and a relaxation technique based on Öst's treatment were used as the interventions. The collected data were analyzed with a multivariate analysis of covariance (MANCOVA), a Chi-square test, and the Bonferroni procedure of post-hoc analysis.The relaxation training method was significantly more effective than both metaphor therapy and the lack of treatment in reducing the patients' beliefs of hopelessness in the face of changes and emotional irresponsibility, as well as the pain severity. Metaphor therapy was not effective on any of these factors. In fact, the results did not support the effectiveness of metaphor therapy.Regarding the effectiveness of the relaxation method as compared with metaphor therapy and the lack of treatment in the control group, this study suggests that relaxation should be paid greater attention as a method for improving the status of patients. In addition, more studies are needed to determine the effectiveness of metaphor therapy in this area.